The genus Clostridium is ubiquitous [1] 
Due to the wide variability of methods that have been developed for detection, quantification of BoNT, one way to simplify this information is to group them as proposed Dorner et.al. [85] 1-Immunological assays (detecting the presence of the Toxin). 2-In vitro biochemical methods (detecting the catalytic activity and the serotype) 3-Functional (Measure the full biological activity and toxicity)
Previously, a few articles reviewed widely assays for BoNT detection, quantification in different matrices (foods, biological samples) until 2015 [57, 70, [85] [86] [87] [88] [89] . In this chapter, we will focus on to the most latest methods developed for BoNT, including works from 2016.
One of the features mostly used for analytical detection of BoNT is the proteolytic function of the BoNT light chain [90] . Colorimetric, fluorimetric and luminescence methods were developed [91] [92] [93] [94] , however these did not show a suitable limit of detection or if they did, the need of specialized equipment, make them unsuitable for point-of-care applications. Shan Chen et. al. [95] developed a new and easy to use colorimetric detection of functional BoNT mediated by gold nanoparticles agglomeration. This work is based on the ability of active BoNT to enzymatically cleave SNAptide®, a synthetic peptide that acts as substrate. Cleaved peptides induce the agglomeration of gold nanoparticles, and then changes in the solution color can be detected. For this purpose SNAptide was modified by introducing biotin at one end and cysteine on the other termini. When BoNT is present, modified SNAptide is enzymatically cleaved by the toxin. Then the fragments with the biotin end are removed using magnetic microparticles containing streptavidine and gold nanoparticles are added to bind the cleaved peptide with a cysteine end, afterwards Cu2+ is added. The Cu2+ has a strong affinity to the amine groups on the peptide fragments, the peptide act as a bridge to numerous gold nanoparticles-peptide fragments, leading to the agglomeration of gold nanoparticles, leading to color change. In the case BoNT is absent; the gold nanoparticles continue monodispersed after all modified SNAPtide are removed with magnetic streptavidin microparticles.
A colorimetric signal can be discerned by the naked eye at a concentration of 1 ng/mL, the limit of detection can be improved by measuring the spectral absorbance of the resulting suspension, to a 0.25 ng/mL. This method for detection of the active BoNT has the advantage of being fast, simple, of not requiring sophisticated equipment and having a low limit of detection, as to be implemented in health centers of low resources. What if required would be more interference studies of the matrix.
Emina Wild et. al [96] describe a combined in vitro assay for the detection of active BoNT /B, it takes into account the binding as well as the protease function of the toxin, in that way measuring its biological activity. Its development is mainly intended to determine the potency of said toxin, in the products thereof, with cosmetic application, which is usually accomplished by performing LD50 test in mice. They are describing an interesting alternative in vitro assay for the potency determination of the BoNT / B, reaching a detection limit below 0.1 mouse LD50/ml. In this assay of the BoNT/B binding and cleavage, the toxin is primary bound to its specific receptor previously immobilized in a well plate. Following, the proteolytic subunit of the toxin is activated by chemical reduction of the inter-chain disulfide bond, the L-chain is recovered from the supernatant and transferred to a plate coated with synaptobrevin (specific substrate of the L-chain) and incubated to allow the cleavage reaction. After washing steps, the proteolytic cleavage is quantified by an antibody-mediated detection of the neoepitope. This technique would be useful to replace the LD50 assay, since the authors shown that it is at least equally sensitive or even lower and in turn specifically detect only active BoNT molecules. As a comparative advantage is robust and easy to standardize. It is very important to note that the method described above covers the two most significant toxin functions by evaluating the integrity of the binding domain as well as the proteolytic activity. Other assays for the detection of active BoNTs only evaluate one of the functions of the toxins (proteolytic activity) [67, 97] but are not sufficient to reliably discriminate therapeutically active from inactive BoNT molecules. As the authors express to promote the inclusion of the method in the European Pharmacopoeia would lack validation studies.
Immunological methods, has been extensively used to detect BoNTs, however they often present interference from the matrix, and may give false positives [98] . Accordingly, electrochemical biosensors are real alternative for BoNTs detection, having the characteristics of simplicity, momentum, high sensitivity, and lower costs. Abbas Afkhami et. al. [99] developed an impedimetric immunosensor for a rapid and sensitive immunoassay of BoNT/A, with a detection limit of 0.11 pg/mL. They use a carbon electrode with Au nanoparticles/graphene-chitosan for signal amplification, with anti-BoNT/A antibodies immobilized. To detect BoNT/A, they employ the impedance changes, generated by the specific immuno-interactions at the immunosensor surface. They further determined that the measurements were highly specific and have a linear correlation with BoNT/A concentrations in different matrix (PBS, milk and human serum). This immunosensor showed a good sensitivity, a low detection limit, reproducibility, storage stability and low cost compared to other sensors [99] , which would allow its implementation in the market.
In the past years, significant progress has been made in the detection of BoNTs primarily because their clinical importance and their potential use in bioterrorism. There is a vital need for rapid in vitro diagnostics that can be validated to replace the mouse bioassay, currently there are no in vitro method that can play that role. To the clinical need, the detection time must be much less than the mouse bioassay, and with a limit of detection equal to or less than this technique. Today several developments to BoNT detection were based on a combination of methods; immunological; functional methods; biochemical methods. These not only contemplate absence and presence, but functionability and in some cases potency, which makes them possible candidate to replace the mouse bioassay, but should have a strong validation against it.
C. difficile TOXINS
Clostridium difficile is the leading cause of hospital diarrhea in developed countries and an increasingly common etiology of community diarrhea. In several cases cause pseudomembranous colitis and even death [100] . Even though, the major risk factors in patients are the past of antibiotic treatment, an age of over 65 years, and prolonged hospitalization. Toxigenic strains of C. difficile produce the toxin A and B exotoxins that mainly cause the symptoms of Infection C. difficile. In addition, some strains produce the binary toxin, whose role in the pathogenesis is not yet very clear [101] [102] [103] . The reference method for the detection of C. difficile is cytotoxicity of stool in cell culture, is recognized as the most sensitive method for detection of C. difficile, but its specificity is low, it does not distinguish between toxigenic and non-toxigenic isolates and requires 24 -48 h to obtain the first results [104] . Therefore, stool culture testing can be coupled with a cell cytotoxicity assay or EIA (enzyme immunoassay) to detect toxins producing C. difficile strains [105] , resulting in increased specificity [106] . Detection techniques for toxins A and/or B using EIA are quick [105, 107] , simple and low cost; low sensitivity and not enough good specificity dismiss them as infection C. difficile diagnostic. The sensitivity and specificity of EIAs ranged from 32% to 83% and from 84% to 100%, respectively [107] [108] [109] [110] . Therefore, the overall poor performance of toxin EIAs led to the recommendation to use them only as a part of a two-or three-stage algorithm [3, 104] . The main disadvantage of these techniques is their lack of sensitivity, when compared to the toxigenic culture. The behavior of these techniques can lead to a large number of false positives and false negatives. False positives may lead to unnecessary treatment of C. difficile infection, withdrawal of other antibiotics, and inadequate isolation of the patient who may sometimes share a room with a true case of C. difficile infection. On the other hand, false negatives may prevent patient from treatment and favor the dissemination of the pathogen in the hospital environment [110, 111] . As alternative the detection of the enzyme glutamate-dehydrogenase (GDH) could be a good choice, this protein is produced constitutionally and in large quantities by most strains of C. difficile. The sensitivity of detection is high, with values close to 90% when compared to the toxigenic culture, however, it has a positively low specificity and predictive value because it detects both, producing and non-producing toxin strains [110, 112] .
So far there, are several reviews of the molecular methods developed to detect C. difficile toxins, and their use for diagnosis [100, 107, 110, 111, [113] [114] [115] . In the last two years, some immunoassays have been developed [116] [117] [118] [119] that can overcome the stagnation of C. difficile toxin detection. These methods, are in many cases simples, fast and ultrasensitive, and have a large potential for clinical applications in the future.
An example is the Yi-Wei Tang et al. [120] real-time cellular analysis for detection a functional toxin B. The cells were cultured in microelectrode and were monitored by changes in electrode impedance. Toxin cause cytotoxic effects on the cells and this resultes in decrease of the electronic impedance, reflecting the cell number, cell morphology, and cell adhesion degree. This technique had a specificity of 99.6% and a sensitivity of 87.5% (28 of 32), which is higher than the EIA result. When a pre-step of immunomagnetic separation enrichment process is added, in which toxin B is first captured from supernatant via magnetic beads [116] , the specificity raises to 99.7%.
Other example is the ELISA developed by Linan Song et. al. [117] , an ultrasensitive toxin detection based on single molecule array technology. This assay was validated using culture filtrates prepared from a panel of clinical C. difficile strains and adult clinical stool specimens. The detection limit reported is 0.45 pg/mL for toxin A and 1.50 pg/mL and for toxin B.
Despite the evident progress in the development of different rapid diagnostic techniques over the past decades, in terms of C. difficile infection, for the moment no cost-effective rapid diagnosis tests are available.
There have been many advances in the understanding of the pathogenic ways and mechanisms with the host interactions at molecular level of C. difficile [100, 103, 121] , but still a transcendental question continue to arise, whether the fecal presence of this organism equates to disease.
C. Novyi TOXINS
Alpha-toxin from C. novyi is part of the family of large clostridial cytotoxins that also include toxin A and toxin B of Clostridium difficile, and the hemorrhagic and the lethal toxin of Clostridium sordellii [122] .
Clostridium novyi is classified into A, B, C, and D, according to the respective soluble antigens. Only types A and B synthesize the lethal alpha-toxin [123] , type A is implicated in gas gangrene infections in man and animals [124, 125] and type B is the cause of black disease in sheep and other animals [126] both causing important economic losses. In addition, illicit substances users are under risk of infection with clostridium species by injection, which can cause gas gangrene, leading to severe illness or death [124, 125, [127] [128] [129] .
Particularly, for C. novyi, there are two possible scenarios in which rapid tests are required for the detection of alpha toxin; 1) In monitoring the production of toxin in industrial reactors for vaccine fromulation and 2) for rapid diagnosis in health care centers. 1) In cattle the way to prevent this disease is vaccination, employing vaccines produced with toxoids or with toxoids and bacterins [17, [130] [131] [132] .
The standardization of culture in industrial reactors is complex, since the release of toxin into the medium is quite erratic between batches, starting and reaching its peak at different times [130, 133] . At present, toxin concentration is measured by using in vivo methods by means of experimental animals, which have clear drawbacks. On one hand, they need to use a lot of animals and on the other hand the results are provided only 72h after sampling [134] , at that time the state of the culture could have changed, coming to have degradation of the toxin.
An ELISA has been developed for the purpose of monitoring the release of toxin into the culture medium and/or for use in the measurement of toxoid in the final preparation [135] , with a detection limit of 1ng/mL ng/ml toxin. This technique is laborious to implode for the measurement of toxin levels in the reactor, since in total between the washes and antibodies incubation, it would take more than 1h its realization, if it is an excellent technique to quantify the toxoid, since it has a low limit of detection.
In our laboratory we had prepared a latex agglutination reagent rapid test for detecting alphatoxin of C. novyi B for use in Veterinary Vaccine Industry, showing a detection limit of 4 µg/mL [133] . This reagent is successfully used in the company to monitor toxin production in industrial reactors, since the operator can make an informed decision to stop the process in just 5 min. This method has several advantages compared to current in vivo method, first it does not use animals, does not require sophisticated equipment or highly skilled personnel, results are available in only 5 min, the titration curve of toxin is provided in real time wich allows to the operator to make an informed decision to stop the process.
According to the European Pharmacopoeia [136] the potency testing of C. novyi (type B) vaccines for veterinary use, requires inoculation of laboratory rabbits followed by toxin neutralization test in mice.
Erika Borrmann et al. [137] based on the ability of the α toxin to produce cytopathic effect [138] [139] [140] , evaluated whether it is possible to replace the animal test with a cell assay. They demonstrate that the three cell lines tested (ESH-L cells, Vero cells, SFT-R cells) are suitable indicators of toxicity of C. novyi B α toxin in the toxin neutralization test, and that on the three cell lines the results are reproducibly. These results are the preliminary point for the progress of the neutralization test using cell cultures.
2) No rapid test for detection of C. novyi α toxin in health centers is currently available, diagnostic is based on culture and observing cytopathic effect in different cell lines [125, 127] .
The incidence of C. novyi infections in humans is relatively low, but on the other hand this infection has a mortality rate around 50% [125, 127, 129] . Because of this high mortality, this concern of having rapid and sensitive tests should be on the research and development schedule of the scientific community
C. Sordellii TOXINS
Clostridium sordellii cause enteritis and enterotoxemia in cattle [141] and sheep [142] [143] [144] and myonecrosis [145] and gangrene in humans [5, 146] . Gynecological infections in human after childbirth and abortion [147] [148] [149] [150] , post-operative infections [4] , and necrotizing soft tissue infections associated with heroin use [4, 151] can be attributable to infection with C. sordellii. Two toxins are a main responsible virulence factors of C. sordellii: hemorrhagic toxin (TcsH) and lethal toxin (TcsL) [152] [153] [154] [155] . The mortality rate for patients with C. sordellii infection is 40-69%, and most patients die within days or even hours after the initial presentation [4] . For that reason, premature diagnosis of C. sordellii infection is of main importance; the low prevalence of the illness and the fact that the initial symptoms are nonspecific make a precise diagnosis very difficult. The time lapse between the beginning of symptoms and death is frequently so short that does not allow to initiate an empirical antimicrobial therapy. Currently, the C. sordellii diagnostic is determined by means of anaerobic cultures of blood, which is not only time consuming but also is limited to certain laboratory facilities that not all hospital laboratories have, thus do not perform antimicrobial testing on anaerobes. All this, demonstrates the need to research and develop molecular techniques to rapidly detect and identify C. sordelli infection, and one possibility is to diagnose through the presence of its toxins.
Resembling C. novyi, this infection can be controlled with vaccination [154] in animals, in the production of the toxins at the industrial level, the same problems occur (used later in the formulation of the vaccine). For this reason in our laboratory we had prepared a latex agglutination reagent rapid test for detecting TcsL-toxin of C. sordelli [156] .
The latex reagent for C. sordellii lethal toxin presented a detection limit 8ng/mL, specificity was analyzed by testing cross-reactivity with cultures of C. novyi B,C. septicum, C. tetani, C. botulinum types C and D, C. perfringens C, and C. perfringens D. No agglutination was observed in any of them [156] . The methods described herein are rapid and inexpensive, they may be used next to the reactor, provide immediate results, do not require sophisticated equipment or skilled personnel, and are consistent with the trend to reduce, refine, and replace animal use [157] .
C. Tetani TOXINS
C. tetani is classified into 10 serological types (types I to X) based on agglutination. All strains produce the same toxin, tetanus toxin, a 150 kDa protein [158] , which binds to the nerve centers and causes muscular contractions. This can be fatal by blocking the respiratory muscles [159] . Tetanus is totally preventable by active immunization. Since the disease does not give immunity to whoever suffers it, vaccination is the first support to avoid clinics manifestations, or at least, decrease the severity of these [160] .
Even though less common in the developed world, it is a important infection in developing countries, where mortality remains high [161] . Although the implementation of immunization programs, a large number of cases have been reported from the developing world [162] [163] [164] [165] , being the most common cause of otogenic tetanus the trauma followed by lesion contamination [166] . In developed countries, it has been observed that tetanus infections occur in immunosuppressed patients, diabetics, the elderly who were not vaccinated in their childhood, and patients older than 50 years with serological tests with low levels of antibodies against tetanus toxin [167, 168] . For this reason nowadays many efforts are focused on improving techniques for measuring antibodies against this toxin [169] [170] [171] [172] and in the development tetanus neurotoxin neutralizing antibodies [171, 173, 174] .
Clinically diagnosis, it is counted with the spatula test, this is the most useful and a simple bedside diagnostic test for tetanus, being 100% specific and 94% sensitive. Laboratory diagnosis of tetanus infection is carried out only to confirm the clinical diagnosis. Mainly, it is based on the culture of the samples using the appropriate culture media, this method is positive in only 30% of cases of tetanus, because many organisms are killed when exposed to air during sampling process. At the laboratory level, it can also be performed the toxigenicity test, in vitro neutralization test on blood agar or in vivo neutralization test in mice [158, 175] . Unlike other Clostridium, there is not a great call for novel diagnosis methods that would encourage the development of new techniques.
Vaccines have played a definite role in the success of global immunization programmes. Regarding the vaccine manufacture, the stability of the vaccine during production, storage and transport is a major concern. The losses of the potency as well as the confirmation of absence of residual toxicity are the main aspects subjected to control. At different batches the variation is common [176] , so that quality control of various batches is thus a central issue.
In case of tetanus toxoid, a standard method of analysis for testing the antigenic purity is ELISA [177, 178] . Harshvardhan B. Modh et al. [179] replaced the antibodies in the conventional ELISA for the detection of tetanus toxoid by using an aptamer. The aptamer-based assay (ALISA) was able to detect 1ng of tetanus toxoid, which was the same as with ELISA. The aptamer, show high affinity, are easier to handle and manipulate since they are synthesized in vitro.
The elimination of residual toxicity in each batch of tetanus toxoid is subject to strict safety testing. Currently the safety tests have to be performed following in vivo toxicity tests in guinea pigs [180] . However, a replacement by an in vitro method would be desirable. Heike A. BehrensdorfNicol et al. [30, 181] developed a method which detects active tetanus neurotoxin based on their proteolytic activity and specific receptor-binding capacity (BINACLE assay). For the BINACLE assay tetanus neurotoxin is bound to immobilized ganglioside GT1 reduced to liberate and activate the Lchains, then is transferred to a plate containing recombinant synaptobrevin-2, this is cleaved by active Lchains, and the fragment is detected. The tetanus neurotoxin only generates a signal if they have intact binding and protease domains, and if both domains can be separated by reduction, this is equivalent to the in vivo test. The detection limit of the BINACLE assay for pure TeNT is 0.03 ng/ml, Being more sensitivity than the animal test (0.1 ng/ml). This technique that combines binding and cleavage functions, it more consistently to discriminate between toxic and detoxified molecules than other in vitro assays, which detect one a single toxin function (e.g. endopeptidase assays [182] ).
C. perfringens TOXINS
C. perfringens is classified into 5 types (A-E) depending whether they produce one or more of the major toxins: alpha, beta, epsilon, and iota, which have lethal, necrotic and cytotoxic activities [183] . All types produce alpha toxin, besides alpha toxin, type B produce beta and epsilon toxins, type C produce beta toxin, type D epsilon and type E, iota. Also recently identified a binary enterotoxin of C. perfringens, as the novel virulence factor cause of a gastroenteritis [184] . C. perfringens is the most important Clostridium species causing gas gangrene [185, 186] , and is related to variety of infectious disease: myonecrosis in humans and animals (A strains); lamb dysentery (B strains); necrotizing enterocolitis (C strains); enterotoxemia of sheep (D strains), and are the cause of enterotoxemia in calves and lambs (E strains) [187] [188] [189] [190] [191] [192] [193] [194] [195] .
Infection caused by Clostridium perfringens is assumed only after physical exam and in relational to history of the patient [196] . Laboratory diagnosis of C. perfringens can be done by bacteriologic culture as well as by detecting a bacterial toxin [197] [198] [199] [200] . Nowadays genetic methods are available and allow a rapid much typing of C. perfringens [201] [202] [203] [204] . These techniques are precise and quick; but only suggest a gene's existence, and can assure neither a present nor an active toxin that could be responsible of physical damage. This is a problem taking into account that the microorganism is ubiquitous and can be present in on soil, water as well as the gastrointestinal tracts of various mammals, including humans [205] , one alternative is de real time PCR [206] .
As mentioned above, all subtypes of C. perfringens produce the alpha toxin, which makes it the clear target for assay development for clinical use [188] . Alpha toxin has been linked to human and other animal sudden infant death syndrome and numerous human deaths related to food poisoning by type A [207] [208] [209] . Since premature diagnosis and harsh treatment are the solution to decreasing morbidity and mortality, development of a rapid sensitive assay for detect and measure C. perfringens alpha toxin is necessary.
Numerous methods are available for detection, quantification of C. perfringens alpha toxin as mouse lethality assays, Dot-ELISA, ELISA and PLC enzymatic activity, these techniques do not have satisfactory low detection limits (19-130 ng/ml) [10, [210] [211] [212] [213] [214] [215] . Other authors have developed a rapid electrochemiluminescence assays of detect alpha toxin in a biological samples like a serum, and urine, they achieve a detection limits of 1.1 ng/ ml toxin [216] .
Epsilon toxin is the third most potent toxin after botulinum and tetanus toxins secreted by Clostridium species, is produced by C. perfringens B and D, and cause lamb dysentery, enterotoxaemia, and fatal disease for domestic animals [10, 205, 217, 218] . Quantification of epsilon toxin in complex matrix like a milk and serum, is possible by mass spectrometry technique developed by Alexandre Seyer et. al. This quantitative assay provides a rapid (few hours) and sensitive detection less than to 5ng/mL. Because, this method requires high-tech equipment it would be a confirmation method for to complement results obtained in the field [218] .
Beta toxin is a virulence determinant in enterotoxaemia and hemorrhagic enterocolitis in the intestine of livestock or humans [219, 220] . Beta toxin is extremely sensitive to the action of trypsin and is destroyed quickly in the intestine, for that reason it is possible that a type B infection could be misdiagnosed as type D [220, 221] . A concluding diagnosis of type B and C infections should not be based only on toxin detection and must be diagnosed by pathological, microbiological form too [197, 221] . Jasmina Kircanski et al. propose a capture ELISA for detection and quantitation of beta2-toxin in intestinal contents of neonatal piglet. The limit of detection achieved is 2.0-3.5ng/ml. Addition of protease inhibitors to the sample prevented degradation of the toxin, nevertheless has to be accompanied by sample processing at low temperature, and acid pH [200] .
Other authors described an ELISA system to detect beta, epsilon and iota toxins with specific antibody to each toxin. This development reported a detection limit of 1ng/mL for the beta toxin and the iota toxin, for the epsilon toxin the detection limit was 0.1ng/mL. The sensitivity of this ELISA is superior by 10-1000 times than that obtained by lethality dose assay [222] .
It is evident that there have not been many advances for the rapid detection of C. perfringens toxins at the protein level.
C. septicum TOXINS
C. septicum is the main etiological agent of spontaneous myonecrosis, even though infection can also manifest as fatal, necrotizing enterocolitis or distal ileitis [223] [224] [225] [226] [227] [228] [229] . It is not part of the normal human intestinal and stool flora [230, 231] possibly is an opportunistic pathogen, but is part of the normal gastrointestinal microbiota of many animals [232, 233] . The toxic products of this Clostridium are called alpha, beta, gamma and delta-toxin. Alpha toxin has necrotic, lethal and hemolytic activities, being the most toxic result of C. septicum [234] [235] [236] . Diagnosis of spontaneous myonecrosis is difficult and the symptoms are result of an fast systemic infection [237] . Due to the low incidence of this infection, no preventive protocols have been developed, the most prone patients (for example immunosuppressed, with a history of gastric diseases) should undergo a preventive diagnosis, but that has not been implemented yet [227, 229, 238] . The work of Michael J. G. Mallozzi et al. [239] show an excellent review of several aspects of the infection of C. septicum encompassing the diagnosis of the same. In this review it is evident the lack of a fast method and that does not need sophisticated equipment for a quick diagnosis. The most recent advances in the diagnosis of this infection are based on PCR and MALDI TOFF [240] [241] [242] [243] . Here is an important niche for the development of rapid alpha toxin detection techniques, since although this infection does not have a high frequency, its outcome is often fatal.
Today, the trend of development of techniques for detecting main clostridials toxins is the use of rapid methods. Mainly, it is based on the need for rapid identification, semi-quantification, for use as diagnostic tool and also useful at industrial level as control of culture process for toxin production. Tendencies of reduction of the use of experimental animals encourage the implementation of these techniques in the industry. In consequence it is crucial to prove the advantages of these rapid methods in order to be implemented over experimental animal use (shorter times, more productive, cost reduction).
